IL17A and COVID-19: IL-17A, the plasma component of Th17 cells, was not significantly different between SARS-CoV-2 infected and non-infected pregnant participants (Supplementary Table 2), nor between COVID-19 vaccinated and non-vaccinated pregnant participants (Supplementary Table 3), as visualized in Figure 2E.